Tesla's Musk discusses vaccine project, car plant with German politicians

Tesla is helping to build mobile molecule printers to make the potential COVID-19 vaccine under development by CureVac

Elon Musk
Musk checked on the progress of that project, meeting earlier with Brandenburg state premier Dietmar Woidke.
Reuters BERLIN
2 min read Last Updated : Sep 03 2020 | 8:45 AM IST

BERLIN (Reuters) - Tesla Inc's CEO Elon Musk met with three German ministers and other senior politicians on Wednesday to discuss the progress of a collaboration between the car maker and a German biotech company and a planned electric vehicle factory.

Ralph Brinkhaus, leader of Chancellor Angela Merkel's CDU/CSU conservative parliamentary bloc, said Musk was satisfied with the progress of Tesla's alliance with vaccine developer CureVac.

On the sidelines of a conference of the parliamentary bloc in Berlin, the Silicon Valley entrepreneur also met economy minister Peter Altmaier, health minister Jens Spahn and research minister Anja Karliczek, but not Merkel.

Tesla is helping to build mobile molecule printers to make the potential COVID-19 vaccine under development by CureVac.

Last November, the U.S. electric carmaker announced plans to build a Gigafactory in Gruenheide in the eastern state of Brandenburg that surrounds Berlin.

Musk checked on the progress of that project, meeting earlier with Brandenburg state premier Dietmar Woidke.

"It was a very pleasant and focused conversation. Elon Musk is familiar with all the details of the Gruenheide Gigafactory," Woidke said in a statement.

 

(Reporting by Andreas Rinke and Christian Krämer; writing by Thomas Seythal and Ludwig Burger; Editing by Elaine Hardcastle)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Elon MuskCoronavirusTeslaCoronavirus Vaccine

First Published: Sep 03 2020 | 8:35 AM IST

Next Story